Clinical Research Detail Title Of Study Efficacy and Safety of AP 12009 in Adult Patients with Recurrent or Refractory Anaplastic Astrocytoma (WHO grade III) as Compared to Standard Treatment with Temozolomide or BCNU: A Randomized, Actively Controlled, Open Label Clinical Phase III Study. Disease Condition Anaplastic Astrocytoma WHO Grade III Phase of Trial Phase-3 Discipline Pharmacology Start date of Trial 3/26/2009 Closing Date of Trial 3/26/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]